COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 398

Article download: 235

International Journal of Clinical Biochemistry and Research


Application of failure mode and effects analysis to minimize quality failures in clinical biochemistry laboratory


Full Text PDF Share on Facebook Share on Twitter


Author Details : Boinapalli Sudhakar, Bhavesh R. Sadariya*

Volume : 5, Issue : 4, Year : 2018

Article Page : 613-616


Suggest article by email


Abstract

Introduction: Quality failures in the clinical laboratories should be analyzed to improve patient safety in hospital. Purpose of this study is to apply failure mode and effects analysis (FMEA) for prospective risks of quality failures and appropriate corrective actions to reduce/prevent errors in clinical biochemistry laboratory.
Materials and Methods: Members of multidisciplinary team were trained to notify quality failures. Each quality failures assigned value from 1 to 5 based on severity, occurrence and detection of failure modes. Risk priority number (RPN) was calculated from severity, occurrence and detection scores (RPN = SI x OI x DI). For highest risk failure modes, FMEA tool was applied in two stages: before and after action plan.
Results: A total 14 high risk failure modes were found and arranged based on their RPN values from high to low score. In 5 highest risk failure modes RPN values before action plan were as follows: Transcription error (RPN=100), Malfunction of reagent (RPN=75), Malfunction of calibrator (RPN=48), Samples taken in wrong tubes (RPN=36) and Sample misplaced in laboratory (RPN=36). After corrective actions taken, we found decrease in RPN values for 5 highest risk failure modes.
Conclusion: FMEA is an effective tool to reduce quality failures in clinical biochemistry laboratories.

Keywords: Failure mode and effects analysis (FMEA), Quality failure, Patient safety, Risk priority number (RPN).

Doi : 10.18231/2394-6377.2018.0130

How to cite : Sudhakar B , Sadariya B R, Application of failure mode and effects analysis to minimize quality failures in clinical biochemistry laboratory. Int J Clin Biochem Res 2018;5(4):613-616

Copyright © 2018 by author(s) and Int J Clin Biochem Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)